Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice
Authors:
- H. Fai PoonHPH. Fai Poon
- William MaragosWMWilliam Maragos
- William M. PierceWPWilliam M. Pierce
- Jon B. KleinJKJon B. Klein
- Vittorio CalabreseVittorio Calabrese
- Chiara CiniCCChiara Cini
- Carlo De MarcoCMCarlo De Marco
- D. Allan ButterfieldDBD. Allan Butterfield
Open Access
- 1 December 2005
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 4 (12) , 1849-1861
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Experimental therapeutics in transgenic mouse models of Huntington's diseaseNature Reviews Neuroscience, 2004
- Neuronal Induction of the Immunoproteasome in Huntington's DiseaseJournal of Neuroscience, 2003
- Increased oxidative damage to DNA in a transgenic mouse model of Huntington's diseaseJournal of Neurochemistry, 2001
- Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6‐hydroxydopamineEuropean Journal of Neuroscience, 2001
- Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortexNeuroscience Letters, 1999
- Oxidative Stress in Huntington's DiseaseBrain Pathology, 1999
- Biochemical abnormalities and excitotoxicity in Huntington's disease brainAnnals of Neurology, 1999
- Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal gangliaAnnals of Neurology, 1997
- The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's diseaseNature Genetics, 1993
- Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's diseaseNature Genetics, 1993